The CMS Reveals First 10 Drugs for Medicare Drug Negotiation

The long-awaited list of the first 10 Part D drugs to be included in the new Medicare Price Negotiation process includes the commonly prescribed rheumatology drugs Enbrel and Stelara. Initial negotiations with the drug manufacturers will begin this fall.

Source: The Rheumatologist - October 9, 2023 Category: Rheumatology Authors: From the College Tags: Practice Support drug pricing Medicare Price Negotiation Source Type: research